APA (7th ed.) Citation

Feroldi, E., Pancharoen, C., Kosalaraksa, P., Watanaveeradej, V., Phirangkul, K., Capeding, M. R., . . . Bouckenooghe, A. Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12–18 months: Randomized, controlled phase 3 immunogenicity and safety trial. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Feroldi, Emmanuel, Chitsanu Pancharoen, Pope Kosalaraksa, Veerachai Watanaveeradej, Kerdpanich Phirangkul, Maria R. Capeding, Mark Boaz, Sophia Gailhardou, and Alain Bouckenooghe. Single-dose, Live-attenuated Japanese Encephalitis Vaccine in Children Aged 12–18 Months: Randomized, Controlled Phase 3 Immunogenicity and Safety Trial. Taylor & Francis Group.

MLA (9th ed.) Citation

Feroldi, Emmanuel, et al. Single-dose, Live-attenuated Japanese Encephalitis Vaccine in Children Aged 12–18 Months: Randomized, Controlled Phase 3 Immunogenicity and Safety Trial. Taylor & Francis Group.